1. Home
  2. MAIR vs BMRN Comparison

MAIR vs BMRN Comparison

Compare MAIR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madison Air Solutions Corporation Class A Common Stock

MAIR

Madison Air Solutions Corporation Class A Common Stock

N/A

Current Price

$25.29

Market Cap

13.0B

Sector

Industrials

ML Signal

N/A

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$65.69

Market Cap

13.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAIR
BMRN
Founded
N/A
1996
Country
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0B
13.0B
IPO Year
2026
1999

Fundamental Metrics

Financial Performance
Metric
MAIR
BMRN
Price
$25.29
$65.69
Analyst Decision
Buy
Analyst Count
0
18
Target Price
N/A
$88.22
AVG Volume (30 Days)
2.8M
1.8M
Earning Date
N/A
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.26
0.77
Revenue
N/A
$1,313,646,000.00
Revenue This Year
N/A
$15.02
Revenue Next Year
N/A
$12.23
P/E Ratio
$96.42
$83.65
Revenue Growth
N/A
17.62
52 Week Low
$24.75
$49.26
52 Week High
$41.89
$70.98

Technical Indicators

Market Signals
Indicator
MAIR
BMRN
Relative Strength Index (RSI) 33.41 51.24
Support Level N/A $64.07
Resistance Level $33.21 $66.28
Average True Range (ATR) 1.22 1.65
MACD 0.06 -0.41
Stochastic Oscillator 8.37 34.95

Price Performance

Historical Comparison
MAIR
BMRN

About MAIR Madison Air Solutions Corporation Class A Common Stock

Madison Air Solutions Corp is an HVAC and indoor air-quality technology company. Its segments are Commercial and Residential. It generates the majority of its revenue from the Commercial segment, which includes Commercial businesses that deliver well-engineered, custom, and semi-custom air quality systems to support process control, regulatory compliance, energy efficiency, and productivity in mission-critical environments; and the Residential segment, anchored by trusted brands like AprilAire, Broan-NuTone, Zephyr, and Others. Its geographic areas are the U.S, the Americas, Europe, and Other. The group generates the majority of its revenue from the U.S market.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: